항우울제의 사용과 체중

키워드

참고문헌 (57)

1. Andrade L, "The epidemiology of major depressive episodes : results from the International Consortium of Psychiatric Epidemiology(ICPE)Surveys", Int J Methods Psychiatr Res, 12, pp.3~21 (2003)
2. Robins LN, "Psychiatric Disorders in America: The Epidemiologic Catchment Area Study" (1991), The Free Press
3. 조맹제, "한국 주요정신장애의 유병률 및 관련요인：2006 전국정신질환역학조사", 신경정신의학, 48(3), pp.143~152 (2009), 대한신경정신의학회
4. Korean Neuropsychiatric Association, "Textbook of Neuropsychiatry" (2017), iMiS Company
5. 송후림, "신경염증과 정신질환", 생물정신의학, 23(1), pp.12~17 (2016), 대한생물정신의학회
6. Leonard BE, "Impact of inflammation on neurotransmitter changes in major depression : an insight into the action of antidepressants", Prog Neuropsychopharmacol Biol Psychiatry, 48, pp.261~267 (2014)
7. Hillhouse TM, "A brief history of the development of antidepressant drugs : from monoamines to glutamate", Exp Clin Psychopharmacol, 23, pp.1~21 (2015)
8. Papakostas GI, "Towards new mechanisms : an update on therapeutics for treatment-resistant major depressive disorder", Mol Psychiatry, 20, pp.1142~1150 (2015)
9. Weilburg JB, "An overview of SSRI and SNRI therapies for depression", Manag Care, 13, pp.25~33 (2004)
10. Benjamin S, "Review of the use of mirtazapine in the treatment of depression", Expert Opin Pharmacother, 12, pp.1623~1632 (2011)
11. Fava M, "Augmentation and combination strategies in treatment-resistant depression", J Clin Psychiatry, 62(Suppl 18), pp.4~11 (2001)
12. Fava M, "Diagnosis and definition of treatment-resistant depression", Biol Psychiatry, 53, pp.649~659 (2003)
13. Nierenberg AA, "Treatment-resistant bipolar depression : a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone", Am J Psychiatry, 163, pp.210~216 (2006)
14. Bahk WM, "Textbook of depressive disorders" (2012), Sigma press
15. 정희정, "새로운 우울증 치료 약물", 생물정신의학, 23(1), pp.1~11 (2016), 대한생물정신의학회
16. Fava M, "Weight gain and antidepressants", J Clin Psychiatry, 61(Suppl 11), pp.37~41 (2000)
17. Diagnostic and statistical manual of mental disorders: DSM-5, "American Psychiatric Association", American Psychaitric Association, ~ (2013)
18. Pan A, "Bidirectional association between depression and metabolic syndrome : a systematic review and meta-analysis of epidemiological studies", Diabetes Care, 35, pp.1171~1180 (2012)
19. Cho SJ, "The relationship between visceral adiposity and depressive symptoms in the general Korean population", J Affect Disord, 244, pp.54~59 (2019)
20. Grundy SM, "Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute", American Heart Association conference on scientific issues related to definition, 2004, pp.24, e13~e18
21. Assari S, "Gender and Ethnic Differences in the association between obesity and depression among black adolescents", J Racial Ethn Health Disparities, 2, pp.481~493 (2015)
22. de Jonghe F, "A randomized, doubleblind study of fluoxetine and maprotiline in the treatment of major depression", Pharmacopsychiatry, 24, pp.62~67 (1991)
23. Michelson D, "Changes in weight during a 1-year trial of fluoxetine", Am J Psychiatry, 156, pp.1170~1176 (1999)
24. Croft H, "A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline", Clin Ther, 21, pp.643~658 (1999)
25. Moon CA, "The effects of psychomotor performance of fluvoxamine versus mianserin in depressed patients in general practice", Br J Clin Pract, 45, pp.259~262 (1991)
26. Shi Z, "SSRI antidepressant use potentiates weight gain in the context of unhealthy lifestyles : results from a 4-year Australian follow-up study", BMJ Open, 7, pp.e016224~ (2017)
27. Fava M, "Fluoxetine versus sertraline and paroxetine in major depressive disorder : changes in weight with long-term treatment", J Clin Psychiatry, 61, pp.863~867 (2000)
28. Aberg-Wistedt A, "Sertraline versus paroxetine in major depression : clinical outcome after six months of continuous therapy", J Clin Psychopharmacol, 20, pp.645~652 (2000)
29. Silverstone PH, "Once-daily venlafaxine extended release(XR)compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group", J Clin Psychiatry, 60, pp.22~28 (1999)
30. Gafoor R, "Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study", BMJ, 361, pp.k1951~ (2018)
31. Alam MY, "Safety, tolerability, and efficacy of vortioxetine(Lu AA21004)in major depressive disorder : results of an open-label, flexible-dose, 52-week extension study", Int Clin Psychopharmacol, 29, pp.36~44 (2014)
32. Tourian KA, "Desvenlafaxine and weight change in major depressive disorder", Prim Care Companion J Clin Psychiatry, 12, pp.e1~e8 (2010)
33. Harto-Truax N, "Effects of bupropion on body weight", J Clin Psychiatry, 44, pp.183~186 (1983)
34. Smith WT, "Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder", Psychopharmacol Bull, 26, pp.191~196 (1990)
35. Cho SJ, "Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.208~211 (2011)
36. Jieun Lee, "The Tolerability of Mirtazapine Augmentation in Schizophrenic Patients Treated with Risperidone: A Preliminary Randomized Placebo-controlled Trial", Clinical Psychopharmacology and Neuroscience, 9(2), pp.73~77 (2011), 대한정신약물학회
37. Montgomery SA, "Mirtazapine versus amitriptyline in the long-term treatment of depression : a double-blind placebo-controlled study", Int Clin Psychopharmacol, 13, pp.63~73 (1998)
38. Goodnick PJ, "Weight change during mirtazapine therapy", Prim Psychiatry, 3, pp.103~108 (1998)
39. Caffey EM Jr, "Side effects and laboratory findings in a study of anti-depressant drugs", Dis Nerv Syst, 23, pp.444~449 (1962)
40. Fernstrom MH, "Antidepressant-induced weight gain : a comparison study of four medications", Psychiatry Res, 26, pp.265~271 (1988)
41. Garland EJ, "Weight gain with antidepressants and lithium", J Clin Psychopharmacol, 8, pp.323~330 (1988)
42. Frank E, "Imipramine and weight gain during the treatment of recurrent depression", J Affect Disord, 20, pp.165~172 (1990)
43. Frank E, "Imipramine and weight gain during the long-term treatment of recurrent depression", J Affect Disord, 26, pp.65~72 (1992)
44. Feiger AD, "Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression", Int Clin Psychopharmacol, 14, pp.19~28 (1999)
45. Sussman N, "Effects of psychotropic drugs on weight", Psychiatr Ann, 29, pp.580~594 (1999)
46. Guaiana G, "Agomelatine versus other antidepressive agents for major depression", Cochrane Database Syst Rev, pp.CD008851~ (2013)
47. Berken GH, "Weight gain. A side-effect of tricyclic antidepressants", J Affect Disord, 7, pp.133~138 (1984)
48. Benazzi F, "Weight gain in depression remitted with antidepressants : pharmacological or recovery effect", Psychother Psychosom, 67, pp.271~274 (1998)
49. Fernstrom MH, "Imipramine treatment and preference for sweets", Appetite, 10, pp.149~155 (1988)
50. Levitt AJ, "The effect of desipramine on body weight in depression", J Clin Psychiatry, 48, pp.27~28 (1987)
51. Bouwer CD, "Phasic craving for carbohydrate observed with citalopram", Int Clin Psychopharmacol, 11, pp.273~278 (1996)
52. Wright DE, "Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain", J Comp Neurol, 351, pp.357~373 (1995)
53. Hoffman BJ, "Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain", FEBS Lett, 247, pp.453~462 (1989)
54. Britton DR, "Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty", Life Sci, 31, pp.363~367 (1982)
55. Levine AS, "Effect of centrally administered corticotropin releasing factor(CRF)on multiple feeding paradigms", Neuropharmacology, 22, pp.337~339 (1983)
56. Pijl H, "Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity", Int J Obes, 15, pp.237~242 (1991)
57. Fernstrom MH, "Depression, antidepressants, and body weight change", Ann N Y Acad Sci, 575, pp.31~39 (1989)

관련 논문AI추천